Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B). (Record no. 17945345)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02223 a2200553 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515120404.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200807s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1556-1380 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1097/JTO.0b013e31816de276 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Jatoi, Aminah |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20080703 |
245 00 - TITLE STATEMENT | |
Title | Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B). |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer |
Date of publication, distribution, etc. | May 2008 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 516-20 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Boronic Acids |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Bortezomib |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Carboplatin |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cardia |
General subdivision | pathology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease Progression |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Esophageal Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Esophagogastric Junction |
General subdivision | pathology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Paclitaxel |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyrazines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Stomach Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Survival Rate |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Dakhil, Shaker R |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Foster, Nathan R |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ma, Cynthia |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rowland, Kendrith M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Moore, Dennis F |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jaslowski, Anthony J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Thomas, Sachdev P |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hauge, Mark D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Flynn, Patrick J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Stella, Philip J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Alberts, Steven R |
773 0# - HOST ITEM ENTRY | |
Title | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer |
Related parts | vol. 3 |
-- | no. 5 |
-- | p. 516-20 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1097/JTO.0b013e31816de276">https://doi.org/10.1097/JTO.0b013e31816de276</a> |
Public note | Available from publisher's website |
No items available.